Surgery Partners Inc (SGRY) financials

NASDAQ · Health Care

$23.21 0.00% Close Oct 30, 2026 Live

Surgery Partners revenue and earnings by year

Surgery Partners's revenue was $3.31 billion in the fiscal year to December 31, 2025, up 6.2% from the year before. Net income was -$77.9 million, -2.4% of revenue. Since the fiscal year to December 31, 2018, revenue has grown 9.3% a year on average.

RevenueNet income
$0$1.00B$2.00B$3.00B
20182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 8 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue3.313.112.742.542.231.861.831.77
Revenue growth6.2%13.5%8.0%14.1%19.6%1.6%3.4%—
Gross profit0.770.750.650.570.490.380.420.41
Gross margin23.1%23.9%23.6%22.6%22.1%20.4%23.1%23.1%
Operating income0.370.330.330.350.300.170.240.07
Operating margin11.1%10.7%12.0%13.7%13.5%9.3%13.0%3.9%
Net income-0.08-0.17-0.01-0.05-0.07-0.12-0.07-0.21
Net margin-2.4%-5.4%-0.4%-2.2%-3.2%-6.2%-4.1%-11.6%
Diluted EPS-$0.61-$1.33-$0.09-$0.59-$1.12-$3.19-$2.29-$4.96
Free cash flow0.240.210.230.090.040.230.070.12

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open SGRY in Markets.

See also: SGRY returns

No forecast, no recommendation. This page describes Surgery Partners Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.